ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон

Видео с ютуба Practicepointcme

Integrating Practice-Changing Updates to Improve Outcomes Among Patients

Integrating Practice-Changing Updates to Improve Outcomes Among Patients

Episode 25 - Recent Progress in NF1-PN: Pathophysiology, Role of MEK Inhibitors, Recognizing the ...

Episode 25 - Recent Progress in NF1-PN: Pathophysiology, Role of MEK Inhibitors, Recognizing the ...

Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Updates from ACR Convergence ...

Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Updates from ACR Convergence ...

Episode 8 - Integrating Practice-Changing Updates to Improve Outcomes Among Patients

Episode 8 - Integrating Practice-Changing Updates to Improve Outcomes Among Patients

Podcast from EHA 2024 - Advancements in Myelofibrosis From Pathophysiology to Personalized Treatm...

Podcast from EHA 2024 - Advancements in Myelofibrosis From Pathophysiology to Personalized Treatm...

Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates ...

Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates ...

Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences

Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences

Case 1: Persistent Dyspnea Despite Guideline-Based Therapy: Time to Rethink the Algorithm?

Case 1: Persistent Dyspnea Despite Guideline-Based Therapy: Time to Rethink the Algorithm?

Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Current and em...

Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Current and em...

COPD Management

COPD Management

Case 2: Recurrent Exacerbations in a Biomarker-Defined Subgroup: What's the Next Step?/Key Takeaways

Case 2: Recurrent Exacerbations in a Biomarker-Defined Subgroup: What's the Next Step?/Key Takeaways

Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring E...

Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring E...

Episode 12 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to T...

Episode 12 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to T...

Episode 9 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 2: HAE Prophylaxis...

Episode 9 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 2: HAE Prophylaxis...

Episode 1 - Talking Cardiovascular Disease Prevention: Emerging Strategies to Address Management ...

Episode 1 - Talking Cardiovascular Disease Prevention: Emerging Strategies to Address Management ...

Episode 1 - Optimizing Outcomes in Psoriasis: Exploring the Impact of Rapid Diagnosis and Emergin...

Episode 1 - Optimizing Outcomes in Psoriasis: Exploring the Impact of Rapid Diagnosis and Emergin...

Episode 12 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 4 Th...

Episode 12 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 4 Th...

Episode 9 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Tr...

Episode 9 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Tr...

Episode 24 - Podcast from EHA 2024 - Advancements in Myelofibrosis From Pathophysiology to Person...

Episode 24 - Podcast from EHA 2024 - Advancements in Myelofibrosis From Pathophysiology to Person...

Следующая страница»

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]